There was also significant reduction of PARP (Poly(ADP-ribose) polymerase-1) and the augmentation of cleaved-PARP in lung cancer cells treated with 10–20 μg/mL (Figure 4(b)). This evidence concerns the gene PARP1 and lung cancer.